With the stock currently trading at Rs 405.05, Biocon has demonstrated strong financial performance and positive investor sentiment, as reflected by its 52-week high and bullish market outlook.

Biopharmaceutical company Biocon is planning to submit a request for approval of generic copies of the blockbuster ...

Little surprise then that Citi was top of Dealogic’s Asia Pacific ex-Japan G3 DCM revenue league table in 2024, with $77 ...

Qualified institutional placements (QIPs) witnessed a resilient growth in July so far, led by State Bank of India's (SBI) ...

Domestic equity benchmarks suffered losses in afternoon deals on Friday amid selling pressure in financial and FMCG shares, ...

In June 2025, mutual funds made aggressive portfolio shifts, with major buying concentrated in stocks like Asian Paints, Dixon Technologies, and Vishal Mega Mart, ...

So far in 2025, a total of 30 companies have raised nearly Rs 60,000 crore via QIPs, building on the strong momentum from ...

The Nifty Pharma index was down 0.59 per cent at 22545.95 at the time of writing this report. Benchmark NSE Nifty50 index was ...

As per the Global Entrepreneurship Monitor, presently, there are more than 658 million active female founders and business ...

Anthem Biosciences IPO Allotment status, Anthem IPO GMP Price: Anthem Biosciences IPO allotment status set to go live today after oversubscription; check your allotment now!

The researchers determined the population health of the butter and littleneck clams living on the Broken Group Islands, ...

Thane's property market has shown significant growth over the last few years. Average 2-BHK prices in Mumbai's Thane suburb ...